Form 4: Twist Bioscience CFO Adam Laponis Sells Shares to Cover Tax Obligations

Adam Laponis, CFO of Twist Bioscience, sold 5,886 shares of common stock on January 10, 2025, to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Summary

• On January 10, 2025, Adam Laponis, the Chief Financial Officer of Twist Bioscience Corp, sold 5,886 shares of common stock.
• The sale was executed at a price of $43.263 per share.
• This transaction was conducted to cover tax withholding obligations associated with the vesting of Restricted Stock Units.
• Following the transaction, Laponis directly owns 110,096 shares of Twist Bioscience Corp.
• The sale was mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person.

Sentiment

Score: 6

Explanation: The document reports a routine transaction (sell to cover taxes) by a company executive. It's neutral in sentiment as it doesn't inherently indicate positive or negative performance for the company.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and do not necessarily indicate a negative outlook on the company's future.

Key Dates